🔎 Trials Near Me

Beranda › Kelebihan Berat Badan › Florida › Miami

Uji klinis Kelebihan Berat Badan di Miami, FL

23 studi untuk Kelebihan Berat Badan mencari peserta di lokasi sekitar Miami (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

Menerima pesertaFase 1
  • Clinical Pharmacology of Miami, Miami
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07399678

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Menerima pesertaFase 3
  • PharmaDev Clinical Research Institute LLC, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Menerima pesertaFase 3
  • Flourish Research Acquisition, LLC dba Flourish Research - North Miami, Miami
  • New Age Medical Research Corporation, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07794579

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Menerima pesertaFase 3
  • Research Associates of South Florida - Miami - Southwest 8th Street, Miami
  • Gastro Health Research - Miami, Miami
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06937099

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Menerima pesertaFase 3
  • Research Associates of South Florida - Miami - Southwest 8th Street, Miami
  • Gastro Health Research - Miami, Miami
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06937086

A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity

Menerima pesertaFase 1
  • Clinical Pharmacology of Miami, Miami
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07803744

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Menerima pesertaFase 3
  • Flourish Research Acquisition, LLC dba Flourish Research - North Miami, Miami
  • New Horizon Research Center, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Menerima pesertaFase 3
  • New Horizon Research Center, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07392190

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Menerima pesertaFase 3
  • Flourish Research - Miami, LLC, Miami
  • PharmaDev Clinical Research Institute, LLC, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Menerima pesertaFase 3
  • Finlay Medical Research, Miami
  • Suncoast Research Group LLC, Miami
  • New Horizon Research Center, Miami
Usia 45 hingga 99 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Menerima pesertaFase 3
  • BioMed Research & Medical Center, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07321886

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Menerima pesertaFase 2
  • New Horizon Research Center, Miami
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07589608

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Menerima pesertaFase 3
  • PharmaDev Clinical Research Institute LLC, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07571005

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Menerima pesertaFase 3Sukarelawan sehat diterima
  • ACCOMPLISH-2 Research Site, Miami
Usia 18 hingga 79 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Menerima pesertaFase 2
  • New Horizon Research Center, Miami
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06143956

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Menerima pesertaFase 3
  • Kailera Clinical Site, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Menerima pesertaFase 3
  • Optimus U Corporation, Miami
  • Research Institute of South Florida, Miami
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Menerima pesertaFase 3
  • Optimus U Corporation, Miami
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07684144

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Menerima pesertaFase 3
  • New Horizon Research Center, Miami
  • Research Institute of South Florida, Miami
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT07575399

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Menerima pesertaFase 3
  • ACCOMPLISH-1 Research Site, Miami
Usia 18 hingga 79 · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT07654361

Community Park-Based Programs for Health Promotion: The Fit2Lead Prospective Cohort Study

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
Usia 12 hingga 17 · Semua jenis kelamin · Diperbarui 10 Sep 2025 · NCT06596265

Community Park-Based Programs for Health Promotion: Fit2Play Prospective Cohort Study

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
Usia 6 hingga 14 · Semua jenis kelamin · Diperbarui 4 Sep 2025 · NCT06595251

Community Park-Based Programs for Health Promotion: Active Older Adults Prospective Cohort Study

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
Usia 50 hingga 95 · Semua jenis kelamin · Diperbarui 4 Sep 2025 · NCT06604650

Uji klinis Kelebihan Berat Badan di kota lain

Studi lain di Miami

Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.